Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
Authors
Keywords
COVID-19, Predictive marker, CCL17, IFN-λ3, IP-10, CXCL9, IL-6
Journal
GENE
Volume 766, Issue -, Pages 145145
Publisher
Elsevier BV
Online
2020-09-14
DOI
10.1016/j.gene.2020.145145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China
- (2020) Jiao Gong et al. CLINICAL INFECTIOUS DISEASES
- Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis
- (2020) John J Y Zhang et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
- (2020) Pingzheng Mo et al. CLINICAL INFECTIOUS DISEASES
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID‐19
- (2020) Yong Gao et al. JOURNAL OF MEDICAL VIROLOGY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
- (2020) Xiaojie Bi et al. PLATELETS
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
- (2020) Guyi Wang et al. Open Forum Infectious Diseases
- Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions
- (2020) Rezvan Noroozi et al. CYTOKINE
- Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients
- (2017) Philip E. Silkoff et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
- (2017) Giulia Finotti et al. Frontiers in Immunology
- Endogenously produced TNF-α contributes to the expression of CXCL10/IP-10 in IFN-λ3-activated plasmacytoid dendritic cells
- (2015) Giulia Finotti et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CCR4 and its ligands: from bench to bedside
- (2014) O. Yoshie et al. INTERNATIONAL IMMUNOLOGY
- Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis
- (2014) Yoko Kataoka JOURNAL OF DERMATOLOGY
- Development of specific and quantitative real-time detection PCR and immunoassays for λ3-interferon
- (2012) Masaya Sugiyama et al. HEPATOLOGY RESEARCH
- Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels
- (2011) Abbas Dehghan et al. CIRCULATION
- Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
- (2011) Svetlana Marukian et al. HEPATOLOGY
- Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus
- (2011) Yukinori Okada et al. HUMAN MOLECULAR GENETICS
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now